Grantham, Mayo, Van Otterloo & Co (GMO)’s Ameren AEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,007
Closed -$314K 656
2025
Q3
$314K Sell
3,007
-4,098
-58% -$409K ﹤0.01% 557
2025
Q2
$682K Buy
7,105
+100
+1% +$9.71K ﹤0.01% 517
2025
Q1
$703K Buy
+7,005
New +$674K ﹤0.01% 497
2018
Q2
Sell
-5,500
Closed -$311K 552
2018
Q1
$311K Sell
5,500
-84,100
-94% -$4.66M ﹤0.01% 519
2017
Q4
$5.29M Buy
+89,600
New +$5.51M 0.03% 224
2017
Q1
Sell
-19,269
Closed -$1.01M 574
2016
Q4
$1.01M Sell
19,269
-3,182
-14% -$158K 0.01% 370
2016
Q3
$1.1M Sell
22,451
-540,214
-96% -$27.6M 0.01% 356
2016
Q2
$30.1M Buy
562,665
+234,365
+71% +$11.5M 0.12% 141
2016
Q1
$16.4M Buy
+328,300
New +$15.1M 0.06% 201

Other funds holding AEE

Grantham, Mayo, Van Otterloo & Co (GMO)'s AEE Position: Q4 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Ameren (AEE) in Q4 2025, closing a stake of 3,007 shares — an estimated $314K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in AEE in Q1 2016 and held it in 9 quarters. The position peaked at $30.1M in Q2 2016. 880 funds tracked by Wall St. Rank hold AEE as of Q4 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Ameren position as of Q4 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 3,007 Ameren shares in Q4 2025, an estimated $314K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Ameren in Q1 2016 and held it in 9 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Ameren position peaked at $30.1M in Q2 2016.
  • 880 funds tracked by Wall St. Rank held Ameren as of Q4 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q4 2025, filed 17 Feb 2026.